Diversified Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.23M | Sell |
90,768
-22,059
| -20% | -$1.27M | 0.08% | 135 |
|
|
2026
Q1 | $6.84M | Sell |
112,827
-13,509
| -11% | -$788K | 0.13% | 88 |
|
|
2025
Q4 | $6.81M | Buy |
126,336
+25,285
| +25% | +$1.22M | 0.13% | 93 |
|
|
2025
Q3 | $4.56M | Buy |
101,051
+36,288
| +56% | +$1.69M | 0.09% | 125 |
|
|
2025
Q2 | $3M | Buy |
64,763
+9,105
| +16% | +$447K | 0.07% | 164 |
|
|
2025
Q1 | $3.39M | Buy |
55,658
+9,503
| +21% | +$554K | 0.08% | 144 |
|
|
2024
Q4 | $2.61M | Sell |
46,155
-14,179
| -24% | -$792K | 0.06% | 180 |
|
|
2024
Q3 | $3.12M | Sell |
60,334
-1,389
| -2% | -$65.2K | 0.08% | 153 |
|
|
2024
Q2 | $2.56M | Sell |
61,723
-9,743
| -14% | -$436K | 0.07% | 163 |
|
|
2024
Q1 | $3.88M | Buy |
71,466
+31,015
| +77% | +$1.58M | 0.12% | 106 |
|
|
2023
Q4 | $2.08M | Sell |
40,451
-6,931
| -15% | -$364K | 0.07% | 164 |
|
|
2023
Q3 | $2.75M | Buy |
47,382
+580
| +1% | +$35.5K | 0.1% | 110 |
|
|
2023
Q2 | $2.99M | Buy |
46,802
+3,218
| +7% | +$216K | 0.11% | 111 |
|
|
2023
Q1 | $3.02M | Buy |
43,584
+12,650
| +41% | +$892K | 0.12% | 103 |
|
|
2022
Q4 | $2.23M | Buy |
30,934
+4,021
| +15% | +$303K | 0.09% | 123 |
|
|
2022
Q3 | $1.91M | Buy |
26,913
+1,169
| +5% | +$84.8K | 0.09% | 115 |
|
|
2022
Q2 | $1.98M | Buy |
25,744
+962
| +4% | +$73.3K | 0.08% | 126 |
|
|
2022
Q1 | $1.81M | Buy |
24,782
+8,975
| +57% | +$603K | 0.06% | 153 |
|
|
2021
Q4 | $986K | Sell |
15,807
-310
| -2% | -$18.2K | 0.03% | 261 |
|
|
2021
Q3 | $954K | Buy |
16,117
+621
| +4% | +$40.9K | 0.03% | 239 |
|
|
2021
Q2 | $1.03M | Buy |
15,496
+177
| +1% | +$11.5K | 0.04% | 236 |
|
|
2021
Q1 | $967K | Buy |
15,319
+614
| +4% | +$38.2K | 0.04% | 222 |
|
|
2020
Q4 | $912K | Buy |
14,705
+106
| +0.7% | +$6.52K | 0.04% | 221 |
|
|
2020
Q3 | $880K | Buy |
14,599
+1,604
| +12% | +$96.5K | 0.04% | 203 |
|
|
2020
Q2 | $764K | Buy |
12,995
+1,073
| +9% | +$64.2K | 0.04% | 196 |
|
|
2020
Q1 | $665K | Sell |
11,922
-132
| -1% | -$8.07K | 0.04% | 165 |
|
|
2019
Q4 | $774K | Buy |
12,054
+472
| +4% | +$27K | 0.03% | 169 |
|
|
2019
Q3 | $587K | Sell |
11,582
-6,661
| -37% | -$313K | 0.03% | 175 |
|
|
2019
Q2 | $827K | Buy |
18,243
+1,988
| +12% | +$92.6K | 0.04% | 145 |
|
|
2019
Q1 | $776K | Buy |
16,255
+4,014
| +33% | +$200K | 0.04% | 150 |
|
|
2018
Q4 | $636K | Buy |
12,241
+4,476
| +58% | +$240K | 0.04% | 160 |
|
|
2018
Q3 | $482K | Buy |
7,765
+30
| +0.4% | +$1.78K | 0.02% | 176 |
|
|
2018
Q2 | $428K | Sell |
7,735
-153
| -2% | -$8.26K | 0.03% | 177 |
|
|
2018
Q1 | $499K | Buy |
7,888
+96
| +1% | +$6.18K | 0.03% | 154 |
|
|
2017
Q4 | $477K | Sell |
7,792
-436
| -5% | -$27.3K | 0.03% | 161 |
|
|
2017
Q3 | $524K | Buy |
8,228
+454
| +6% | +$26.5K | 0.04% | 151 |
|
|
2017
Q2 | $433K | Sell |
7,774
-158
| -2% | -$8.6K | 0.04% | 180 |
|
|
2017
Q1 | $431K | Buy |
7,932
+16
| +0.2% | +$878 | 0.03% | 167 |
|
|
2016
Q4 | $463K | Buy |
7,916
+1,405
| +22% | +$76.8K | 0.04% | 151 |
|
|
2016
Q3 | $351K | Sell |
6,511
-17,880
| -73% | -$1.15M | 0.04% | 197 |
|
|
2016
Q2 | $1.79M | Buy |
24,391
+15,580
| +177% | +$1.1M | 0.21% | 108 |
|
|
2016
Q1 | $563K | Sell |
8,811
-356
| -4% | -$22.5K | 0.06% | 225 |
|
|
2015
Q4 | $631K | Buy |
9,167
+701
| +8% | +$46.3K | 0.07% | 232 |
|
|
2015
Q3 | $501K | Buy |
8,466
+50
| +0.6% | +$3.17K | 0.05% | 263 |
|
|
2015
Q2 | $560K | Buy |
8,416
+200
| +2% | +$13.2K | 0.05% | 277 |
|
|
2015
Q1 | $530K | Sell |
8,216
-1,207
| -13% | -$75.6K | 0.05% | 308 |
|
|
2014
Q4 | $556K | Buy |
+9,423
| New | +$531K | 0.05% | 311 |
|
|
2014
Q2 | $397K | Buy |
+8,186
| New | +$403K | 0.03% | 414 |
|
|
2013
Q4 | $1.73M | Buy |
32,466
+26,980
| +492% | +$1.37M | 0.18% | 105 |
|
|
2013
Q3 | $254K | Hold |
5,486
| – | – | 0.03% | 422 |
|
|
2013
Q2 | $246K | Buy |
+5,486
| New | +$238K | 0.03% | 426 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Diversified Trust's BMY Position: Q2 2026 in Review
Diversified Trust reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, selling an estimated $1.27M and leaving 90,768 shares worth $5.23M. The position accounts for 0.08% of the portfolio, ranked #135.
Diversified Trust first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.84M in Q1 2026. 800 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Diversified Trust held 90,768 shares of Bristol-Myers Squibb worth $5.23M as of Q2 2026.
- Diversified Trust sold 22,059 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.27M.
- Bristol-Myers Squibb made up 0.08% of Diversified Trust's portfolio in Q2 2026, its #135 holding.
- Diversified Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- Diversified Trust's Bristol-Myers Squibb position peaked at $6.84M in Q1 2026.
- 800 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.